ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nextech Announces Key Appointments to Board of Directors

TAMPA, Fla., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Nextech, a leading provider of clinical and administrative healthcare technology solutions for specialty physician practices, today announced several new appointments to its board of directors. The appointments bring to Nextech strategic leadership experience and distinct expertise across healthcare IT and payments. New members include:

  • Halsey Wise, Chairman – Wise brings to Nextech decades of executive leadership at public and private healthcare and technology companies. This experience includes serving as the Chairman and CEO of MedAssets, a leading healthcare performance company, and as Chairman and CEO of Intergraph Corporation, a leading engineering and geospatial software provider. Wise serves on the boards of Lyric and WellSky, and previously, Cerner Corporation, Cotiviti Inc., and Aspen Technology.
  • Anthony Colaluca, Board Member – Colaluca has more than 30 years leading and operating healthcare and technology companies. He has served as the CFO of many industry leaders including MedAssets, Intergraph, Harland Financial Solutions, Solution 6 North America, and Computer Management Sciences.
  • Carl Pascarella, Board Member – Pascarella served as the CEO of Visa USA from 1993 to 2005, where he oversaw the company’s transformation into a leading global payment network. He previously served as President and CEO of the company’s Asia Pacific Region. Pascarella is a veteran of the financial services industry, having held leadership roles at Crocker National Bank and Bankers Trust Company, among other financial institutions.

“Adding this level of talent and expertise to Nextech’s board of directors is a game changer,” said Bill Lucchini, CEO of Nextech. “Pairing such a talented board with a top-tier partner like TPG enables us to make strategic investments in innovative technology and talent. Whether it’s leveraging generative AI, the latest in patient-experience technology, or enhanced patient outcomes, we’re focused on driving value for current and future Nextech clients.”

“The vast majority of healthcare infrastructure still relies on decades-old systems and manual processes,” said Wise. “Nextech is bringing a modernized approach and contemporary solutions to healthcare management, tailored to propel artificial intelligence and enable the unique end markets it serves. I am thrilled to join the board alongside these world-class executives and look forward to partnering with them and Nextech leadership to guide the company through its very exciting next phase of growth.”

The appointments build on a period of momentum for Nextech, following the launch of Nextech Med Spa, the industry’s first solution dedicated to the category, and its recent acquisition by TPG. Wise, Pascarella, and Colaluca join Nextech’s board of directors alongside Lucchini and other existing members.

About Nextech

Nextech is the complete healthcare technology solution for specialty providers. Since 1997, Nextech has been focused on delivering innovative solutions and services that drive efficiency, fuel growth, and enhance the patient care experience. Nextech services more than 16,000 physicians and over 60,000 office staff members in the clinical specialties of Dermatology, Med Spa, Ophthalmology, Orthopedics, and Plastic Surgery.

Chris Farrell 

VP, Marketing 

(813) 998-4229 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.